文献速递流行病学与生物统计真实世界研究与卫生经济

人体测量与肥胖指标及2型糖尿病风险:队列研究的系统综述与剂量反应Meta分析

Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies.
PubMed 文献 · BMJ · 2022-01-18

体质指数每增加5单位、腰围增加10 cm的2型糖尿病相对风险分别为1.72和1.61,中心性肥胖指标与风险呈正向线性关联。

要点

  • 体质指数每增加5单位,2型糖尿病风险RR=1.72(95%CI 1.65–1.81)。
  • 腰围每增加10 cm,风险RR=1.61(95%CI 1.52–1.70)。
  • 腰围与风险独立于总体肥胖程度,呈强正向线性关联。

核心结论

  • 较高的体质指数与较高的2型糖尿病发病风险相关。
  • 腰围较大独立于总体肥胖程度,与2型糖尿病风险呈强正向线性关联。

研究设计与样本

  • 系统综述与队列研究的剂量反应Meta分析,检索PubMed、Scopus和Web of Science截至2021年5月1日。
  • 纳入一般成人中总体或中心性肥胖及体脂含量与2型糖尿病风险关联的队列研究,两位作者重复提取数据。
  • 采用随机效应剂量反应Meta分析估计关联程度,曲线关联用一阶段加权混合效应Meta分析建模。

主要发现

  • 体质指数每增加5单位,相对风险为1.72(95%CI 1.65–1.81;n=182项研究)。
  • 腰围每增加10 cm,相对风险为1.61(95%CI 1.52–1.70;n=78项研究)。
  • 腰臀比每增加0.1单位相对风险1.63(95%CI 1.50–1.78;n=34),腰高比每增加0.1单位相对风险1.73(95%CI 1.51–1.98;n=25)。
  • 内脏脂肪指数每增加1单位相对风险1.42(95%CI 1.27–1.58;n=9),体脂百分比每增加10%相对风险2.05(95%CI 1.41–2.98;n=6)。
  • 体型指数每增加0.005单位相对风险1.09(95%CI 1.05–1.13;n=5),身体肥胖指数每增加10%相对风险2.55(95%CI 1.59–4.10;n=4),臀围每增加10 cm相对风险1.11(95%CI 0.98–1.27;n=14)。

关键数值与推荐

  • 体质指数与2型糖尿病风险呈强正向线性关联。
  • 各地区和种族均呈正向线性或单调关联,未在特定切点值处出现明显偏离线性。
  • 中心性肥胖指标独立于总体肥胖程度,与2型糖尿病风险呈正向线性或单调关联。
  • 总脂肪量和内脏脂肪量也呈正向线性或单调关联,但研究数量较少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To present a comprehensive review of the association between measures of body weight, waist, and fat, and different ratios of these measures, and the risk of type 2 diabetes. DESIGN: Systematic review and dose-response meta-analysis of cohort studies. DATA SOURCES: PubMed, Scopus, and Web of Science up to 1 May 2021. REVIEW METHODS: Cohort studies looking at the association between general or central adiposity and body fat content and the risk of type 2 diabetes in the general adult population were included. Two of the authors extracted the data in duplicate. Random effects dose-response meta-analyses were performed to estimate the degree of the associations. Curvilinear associations were modelled with a one stage weighted mixed effects meta-analysis. RESULTS: 216 cohort studies with 2.3 million individuals with type 2 diabetes among 26 million participants were identified. Relative risks were 1.72 (95% confidence interval 1.65 to 1.81; n=182 studies) for an increase in body mass index of 5 units, 1.61 (1.52 to 1.70; n=78) for a 10 cm larger waist circumference, 1.63 (1.50 to 1.78; n=34) for an increase in waist-to-hip ratio of 0.1 units, 1.73 (1.51 to 1.98; n=25) for an increase in waist-to-height ratio of 0.1 units, 1.42 (1.27 to 1.58; n=9) for an increase in visceral adiposity index of 1 unit, 2.05 (1.41 to 2.98; n=6) for a 10% higher percentage body fat, 1.09 (1.05 to 1.13, n=5) for an increase in body shape index of 0.005 units, 2.55 (1.59 to 4.10, n=4) for a 10% higher body adiposity index, and 1.11 (0.98 to 1.27; n=14) for a 10 cm larger hip circumference. A strong positive linear association was found between body mass index and the risk of type 2 diabetes. Positive linear or monotonic associations were also found in all regions and ethnicities, without marked deviation from linearity at a specific cut-off value. Indices of central fatness, independent of overall adiposity, also had positive linear or monotonic associations with the risk of type 2 diabetes. Positive linear or monotonic associations were also found for total and visceral fat mass, although the number of studies was small. CONCLUSIONS: A higher body mass index was associated with a greater risk of developing type 2 diabetes. A larger waist circumference, independent of overall adiposity, was strongly and linearly associated with the risk of type 2 diabetes. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021255338.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Jayedi A, Soltani S, Motlagh SZ, et al. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ. 2022. PMID: 35042741. doi:10.1136/bmj-2021-067516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。